Raia Drogasil S.A. (RADL3.SA)
- Previous Close
24.95 - Open
25.14 - Bid 25.70 x --
- Ask 25.64 x --
- Day's Range
24.99 - 25.62 - 52 Week Range
24.30 - 30.15 - Volume
4,982,700 - Avg. Volume
8,411,264 - Market Cap (intraday)
43.941B - Beta (5Y Monthly) 0.34
- PE Ratio (TTM)
41.32 - EPS (TTM)
0.62 - Earnings Date May 7, 2024
- Forward Dividend & Yield 0.20 (0.76%)
- Ex-Dividend Date Apr 18, 2024
- 1y Target Est
30.95
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. It also markets its goods through telesales and call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.
www.rd.com.br57,700
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: RADL3.SA
Performance Overview: RADL3.SA
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RADL3.SA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RADL3.SA
Valuation Measures
Market Cap
43.94B
Enterprise Value
50.60B
Trailing P/E
41.17
Forward P/E
33.33
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.28
Price/Book (mrq)
7.38
Enterprise Value/Revenue
1.49
Enterprise Value/EBITDA
18.70
Financial Highlights
Profitability and Income Statement
Profit Margin
3.11%
Return on Assets (ttm)
7.05%
Return on Equity (ttm)
19.02%
Revenue (ttm)
33.97B
Net Income Avi to Common (ttm)
1.05B
Diluted EPS (ttm)
0.62
Balance Sheet and Cash Flow
Total Cash (mrq)
412.32M
Total Debt/Equity (mrq)
117.24%
Levered Free Cash Flow (ttm)
478.27M
Research Analysis: RADL3.SA
Company Insights: RADL3.SA
RADL3.SA does not have Company Insights